Eberconazole

Eberconazole is an antifungal drug. As a 1% topical cream, it is an effective treatment for dermatophytosis, candidiasis, and pityriasis.^[1][2][3]

Trade namesEbernet

Legal status

• US: Not FDA approved

CAS Number

• 128326-82-9

PubChem CID

• 72051

Quick facts Clinical data, Trade names ...

Eberconazole

Clinical data
Trade names	Ebernet
Legal status
Legal status	US: Not FDA approved
Identifiers
IUPAC name 1-(1,3-Dichloro-6,11-dihydro-5H-dibenzo[1,2-a:1',4'-e] [7]annulen-11-yl)imidazole
CAS Number	128326-82-9
PubChem CID	72051
ChemSpider	65038
UNII	V7O1U41C9B
CompTox Dashboard (EPA)	DTXSID90926104
Chemical and physical data
Formula	C18H14Cl2N2
Molar mass	329.22 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1CC2=CC(=CC(=C2C(C3=CC=CC=C31)N4C=CN=C4)Cl)Cl
InChI InChI=1S/C18H14Cl2N2/c19-14-9-13-6-5-12-3-1-2-4-15(12)18(17(13)16(20)10-14)22-8-7-21-11-22/h1-4,7-11,18H,5-6H2 Key:MPTJIDOGFUQSQH-UHFFFAOYSA-N

Close

It was approved for use in Spain in 2015 and is sold under the trade name Ebernet.^[4] It is also approved for use in Panama, Guatemala, Costa Rica, Honduras, and the Dominican Republic.^[1]